The hedge fund’s shares of CHS are valued at $2.17 million. CHS makes up about 0.35 percent of Rhenman’s portfolio, according to Trade Calls.
Other hedge funds, including Tradelink Capital and Deltec Asset Management, also lowered their stakes in CHS in the most recent quarter.
More articles on healthcare finance:
Indiana woman held by Cancún hospital for $53k bill
8 recent hospital outlook and credit rating actions
Mizuho: Some healthcare companies adjust earnings too much